Sarah Ballinger
Gerontology · Jackson, MSNPI 1538684857
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 9.8% — the pattern of someone who eats at a lot of different presentations.
Across 159 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$287
- Bristol Myers Squibb$287
- Johnson & Johnson$236
- Deciphera Pharmaceuticals Inc.$225
- Pfizer$196
- Sanofi$132
- plus $2K from 31 others
What the payments were for
- Food & beverage$2,82097%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $287 |
| Bristol Myers Squibb | 17 | $287 |
| Johnson & Johnson | 10 | $236 |
| Deciphera Pharmaceuticals Inc. | 11 | $225 |
| Pfizer | 11 | $196 |
| Sanofi | 7 | $132 |
| AbbVie | 6 | $132 |
| Gilead(2 entities) | 6 | $120 |
| E.r. Squibb & Sons, L.L.C. | 6 | $107 |
| Astellas Pharma US Inc | 6 | $104 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $102 |
| Merck | 5 | $90 |
| Array Biopharma Inc | 4 | $78 |
| Tersera Therapeutics LLC | 2 | $68 |
| GSK | 3 | $67 |
| Beigene USA, Inc. | 3 | $66 |
| Genentech USA, Inc. | 5 | $59 |
| AstraZeneca | 3 | $51 |
| Blueprint Medicines Corporation | 3 | $51 |
| Amgen | 3 | $50 |
| Puma Biotechnology, Inc. | 3 | $45 |
| Bayer | 2 | $45 |
| Seagen Inc. | 2 | $34 |
| Genmab U.S., Inc. | 2 | $33 |
| Incyte Corporation | 2 | $30 |
| Sobi, Inc | 1 | $23 |
| Springworks Therapeutics, Inc. | 1 | $23 |
| Sanofi US Services Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| Coherus Oncology, Inc. | 1 | $19 |
| Mirati Therapeutics, Inc. | 1 | $18 |
| G1 Therapeutics, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Celltrion USA Inc. | 1 | $14 |
| CTI Biopharma Corp. | 1 | $12 |
How this compares
$2,920 in reported general payments places this provider in the 80th percentile of 66 gerontology providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 17 | $9,248 |
| EliquisApixaban | 14 | $7,854 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $1,224 |
| Megestrol Acetate | 14 | $1,212 |
| Letrozole | 58 | $838 |
| Dexamethasone | 36 | $780 |
| Tamoxifen Citrate | 38 | $510 |
| Morphine Sulfate ErMorphine Sulfate | 19 | $427 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 28 | $380 |
| Ondansetron Hcl | 36 | $330 |
| Prochlorperazine Maleate | 23 | $247 |
| Gabapentin | 33 | $230 |
| Potassium Chloride | 29 | $229 |
| Hydroxyurea | 14 | $209 |
| Temazepam | 13 | $176 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $236 | $9,24817 claims |
| PfizerEliquis | $196 | $7,85414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 66 gerontology providers in Mississippi.
Other gerontology in Jackson
- Daniel WelchJackson$8K
- Lauren BuffingtonJackson$3K
- Flora GreenJackson$3K
- Shemina RansomJackson$3K
- April CalvertJackson$2K
- Lacey MayfieldJackson$2K
- Ashley SabbatiniJackson$1K
- Gloria JaquesJackson$1K
- Roxane MoncureJackson$1K
- Tracey GrayerJackson$886
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.